Download the Full March 2017 Issue PDF

Participants, who had heart disease or were at increased risk for it, were randomly assigned to celecoxib (100 mg twice a day), ibuprofen (600 mg three times a day) or naproxen (375 mg twice a day), which they took for at least 18 months. There was no significant difference in the occurrence of heart attack, stroke or death between the three groups. One limitation of the study was the high number of people who dropped out. However, the drop-out rate was similar for all three groups, so I dont think it affects the overall conclusions, says Dr. Husni.
To continue reading this article or issue you must be a paid subscriber

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
| |

LEAVE A REPLY

Please enter your comment!
Please enter your name here